Sheetal Buddhadev
Sheetal Buddhadev has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jalpa S. Paun
Government Pharmacy College, Gandhinagar, India
2 shared publications - Ali Hamod AlAmri
Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia
1 shared publication - Bhupendra Gopalbhai Prajapati
Parul University
1 shared publication - Deep D. Undhad
Faculty of Pharmacy, Noble University, Bhesan Road, Junagadh 362001, Gujarat, India
1 shared publication - Dipen R. Bhimani1 shared publication
- Hanan Albataineh
Pharmacy Department, College of Pharmacy, Amman Arab University, Amman, Jordan
1 shared publication
Latest Publications
- 2 May 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (5) , 328
Preparation, Characterization and Evaluation of Griseofulvin-Loaded Transferosomal Gel for Sustained Drug Delivery
- 2 May 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (5) , 328
Preparation, Characterization and Evaluation of Griseofulvin-Loaded Transferosomal Gel for Sustained Drug Delivery
- Open Access
- 23 February 2026
- Published by Peertechz Publications Private Limited in Global Journal of Medical and Clinical Case Reports
- Vol. 13 (2) , 026-031
Pharmacology of Senolytics for Lung Aging and COPD: An Emerging Therapeutic Frontier
Chronic obstructive pulmonary disease is strongly influenced by accelerated lung aging and an accumulation of senescent cells within airway epithelial and immune compartments. Senescent cells release a spectrum of inflammatory mediators that worsen tissue destruction and impair repair mechanisms. Conventional COPD therapeutics do not adequately address cellular senescence, which has led to growing interest in senolytic drugs that selectively eliminate senescent cells or reduce harmful secretory signaling. Several senolytic candidates, including Dasatinib–Quercetin, Fisetin, Navitoclax, HSP90 inhibitors, and peptide-based approaches, have demonstrated promising effects in preclinical respiratory models. These agents modulate pathways such as BCL-2 inhibition, suppression of PI3K/AKT signaling, activation of mitochondrial apoptosis, or disruption of FOXO4–p53 interactions. Early studies suggest potential for reducing chronic inflammation, restoring epithelial function, and slowing structural deterioration in the lung. Although human evidence remains limited and concerns surrounding toxicity, delivery, and biomarker development persist, senolytics represent an emerging pharmacological avenue for targeting lung aging and may hold therapeutic value in COPD.
- 23 February 2026
- Published by Peertechz Publications Private Limited in Global Journal of Medical and Clinical Case Reports
- Vol. 13 (2) , 026-031
Open AccessPharmacology of Senolytics for Lung Aging and COPD: An Emerging Therapeutic Frontier
Chronic obstructive pulmonary disease is strongly influenced by accelerated lung aging and an accumulation of senescent cells within airway epithelial and immune compartments. Senescent cells release a spectrum of inflammatory mediators that worsen tissue destruction and impair repair mechanisms. Conventional COPD therapeutics do not adequately address cellular senescence, which has led to growing interest in senolytic drugs that selectively eliminate senescent cells or reduce harmful secretory signaling. Several senolytic candidates, including Dasatinib–Quercetin, Fisetin, Navitoclax, HSP90 inhibitors, and peptide-based approaches, have demonstrated promising effects in preclinical respiratory models. These agents modulate pathways such as BCL-2 inhibition, suppression of PI3K/AKT signaling, activation of mitochondrial apoptosis, or disruption of FOXO4–p53 interactions. Early studies suggest potential for reducing chronic inflammation, restoring epithelial function, and slowing structural deterioration in the lung. Although human evidence remains limited and concerns surrounding toxicity, delivery, and biomarker development persist, senolytics represent an emerging pharmacological avenue for targeting lung aging and may hold therapeutic value in COPD.
- 16 February 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (3) , 189
Optimization and Characterization of Lafutidine Liquisolid Pellets: A Novel Strategy for Improved Solubility and Drug Release
- 16 February 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (3) , 189
Optimization and Characterization of Lafutidine Liquisolid Pellets: A Novel Strategy for Improved Solubility and Drug Release
- Open Access
- 8 April 2025
- Published by MDPI AG in Engineering Proceedings
- Vol. 87 (1) , 40
Innovative Drug Delivery Systems: The Comprehensive Role of Natural Polymers in Fast-Dissolving Tablets
Fast-dissolving tablets (FDTs) have arisen as a novel way to tackle issues encountered by patients with dysphagia, including youngsters, older people, and those with neurodegenerative or developmental disabilities. This review emphasises the crucial function of natural polymers as super disintegrants in improving fast-disintegrating tablet formulation. Natural polymers, such as chitosan, guar gum, xanthan gum, and fenugreek seed mucilage, are biocompatible, biodegradable, and offer better affordability than synthetics. Natural polymers can quickly break down and disintegrate oral tablets. They also help accelerate drug release bioavailability and patient compliance. This article discusses the benefits of natural polymers, such as environmentally sustainable processing, cost effectiveness, and patient engagement, as well as challenges and limitations. The comprehensive comparison between natural polymers and synthetic polymers emphasises the benefits of natural substances to overcome challenges in the production and promotion of sustainable pharmaceutical practices. Spray drying, freezing, and nanotechnology are advancements in FDT production technology. Apart from its ownership, like Zydis and Durasolv, the combination of these techniques aids in the creation of a medicine system that may be adjusted. They prioritize patients and are also effective. Prospective studies should focus on the expansion of natural polymer procurement and distillation processes to improve the use of FDT.
- 8 April 2025
- Published by MDPI AG in Engineering Proceedings
- Vol. 87 (1) , 40
Open AccessInnovative Drug Delivery Systems: The Comprehensive Role of Natural Polymers in Fast-Dissolving Tablets
Fast-dissolving tablets (FDTs) have arisen as a novel way to tackle issues encountered by patients with dysphagia, including youngsters, older people, and those with neurodegenerative or developmental disabilities. This review emphasises the crucial function of natural polymers as super disintegrants in improving fast-disintegrating tablet formulation. Natural polymers, such as chitosan, guar gum, xanthan gum, and fenugreek seed mucilage, are biocompatible, biodegradable, and offer better affordability than synthetics. Natural polymers can quickly break down and disintegrate oral tablets. They also help accelerate drug release bioavailability and patient compliance. This article discusses the benefits of natural polymers, such as environmentally sustainable processing, cost effectiveness, and patient engagement, as well as challenges and limitations. The comprehensive comparison between natural polymers and synthetic polymers emphasises the benefits of natural substances to overcome challenges in the production and promotion of sustainable pharmaceutical practices. Spray drying, freezing, and nanotechnology are advancements in FDT production technology. Apart from its ownership, like Zydis and Durasolv, the combination of these techniques aids in the creation of a medicine system that may be adjusted. They prioritize patients and are also effective. Prospective studies should focus on the expansion of natural polymer procurement and distillation processes to improve the use of FDT.
- Open Access
- 1 January 2025
- Published by Uphills Publishers LLC in South Eastern European Journal of Public Health
- p. 2769-2774
Application of Plackett–Burman Screening Design for Formulation of Telmisartan Nanosuspension
Developing formulations for medications with low water solubility and low oral bioavailabilitypresents significant challenges. Poor water solubility and a slow rate of dissolution are issuesfor the majority of newly developed and well-established biologically active compounds.Telmisartan (TM) is a BCS class-II medication characterized by low solubility as well as highpermeability. The current study set out to determine crucial formulation and processingcharacteristics that could affect the nanosuspension's quality. Using the nanoprecipitationultrasonication process, a poorly soluble medication was converted into a nanosuspension formulation. In order to screen five independent factors—the amount of stabilizer (mg) (X2), the amount of Telmisartan (mg) (X1), the volume ratio of solvent to anti-solvent (X3), the speed of stirring (RPM) (X4), and the sonication time (min) (X5)—a total of eight experiments werecreated. The dependent factors used were saturation solubility (μg/ml) and mean particle size(nm). The acquired results demonstrated that, in comparison to all other stabilizers, the nanosuspension made with Poloxamer 407 has improved saturation solubility. The amount oftelmisartan and the speed at which the mixture is stirred were also discovered to be potentialformulation and processing parameters that exert considerable influence on the quality of thetelmisartan nanosuspension.
- 1 January 2025
- Published by Uphills Publishers LLC in South Eastern European Journal of Public Health
- p. 2769-2774
Open AccessApplication of Plackett–Burman Screening Design for Formulation of Telmisartan Nanosuspension
Developing formulations for medications with low water solubility and low oral bioavailabilitypresents significant challenges. Poor water solubility and a slow rate of dissolution are issuesfor the majority of newly developed and well-established biologically active compounds.Telmisartan (TM) is a BCS class-II medication characterized by low solubility as well as highpermeability. The current study set out to determine crucial formulation and processingcharacteristics that could affect the nanosuspension's quality. Using the nanoprecipitationultrasonication process, a poorly soluble medication was converted into a nanosuspension formulation. In order to screen five independent factors—the amount of stabilizer (mg) (X2), the amount of Telmisartan (mg) (X1), the volume ratio of solvent to anti-solvent (X3), the speed of stirring (RPM) (X4), and the sonication time (min) (X5)—a total of eight experiments werecreated. The dependent factors used were saturation solubility (μg/ml) and mean particle size(nm). The acquired results demonstrated that, in comparison to all other stabilizers, the nanosuspension made with Poloxamer 407 has improved saturation solubility. The amount oftelmisartan and the speed at which the mixture is stirred were also discovered to be potentialformulation and processing parameters that exert considerable influence on the quality of thetelmisartan nanosuspension.
- 31 October 2023
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 16 (10) , 4943-4951
Self-Nano Emulsifying Drug Delivery System: A Potential Solution to the Challenges of Oral Delivery of Poorly Water-Soluble Drugs
Lipid-based drug delivery systems (LBDDS) are the most promising technique to formulate the poorly water soluble drugs. Nanotechnology strongly influences the therapeutic performance of hydrophobic drugs and has become an essential approach in drug delivery research. Self-Nanoemulsifying drug delivery systems (SNEDDS) are a vital strategy that combines benefits of LBDDS and nanotechnology. SNEDDS are now preferred to improve the formulation of drugs with poor aqueous solubility. SNEDDS are isotropic mixtures composed of oils, surfactants, and occasionally cosolvents. The ability of these formulations and methods to produce nanoemulsions or fine oil-in-water (o/w) emulsions after moderate stirring and dilution by water phase along the GI tract. SNEDDS has garnered attention during recent years as it improves oral bioavailability, reduces drug dose, and increases drug protection from unsuitable environment in the gastrointestinal tract. It can solve the problems related to the dissolution and bioavailability of the Biopharmaceutics Classifcation System Class II and IV drugs. This review shortly describes the ambiguity between nanoemulsions and microemulsions, mechanism of self-emulsifications, composition and function of various excipients of SNEDDS. This review discusses characterization of SNEDDS, advantage of SNEEDS over other emulsion, biopharmaceutical aspects, and limitation as well as future views. The SNEDDS is a potential formulation for drug delivery. Owing to its small particle size, large surface area, high encapsulation efficiency, and high drug loading, the SNEDDS can improve the rate and extent of oral absorption by maximizing drug solubility in the intestinal absorption site. Moreover, because of the lipid-based formulation of SNEDDS, it can stimulate and enhance lymphatic transport of drugs to avoid hepatic first-pass metabolism, and thus improve their bioavailability.
- 31 October 2023
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 16 (10) , 4943-4951
Self-Nano Emulsifying Drug Delivery System: A Potential Solution to the Challenges of Oral Delivery of Poorly Water-Soluble Drugs
Lipid-based drug delivery systems (LBDDS) are the most promising technique to formulate the poorly water soluble drugs. Nanotechnology strongly influences the therapeutic performance of hydrophobic drugs and has become an essential approach in drug delivery research. Self-Nanoemulsifying drug delivery systems (SNEDDS) are a vital strategy that combines benefits of LBDDS and nanotechnology. SNEDDS are now preferred to improve the formulation of drugs with poor aqueous solubility. SNEDDS are isotropic mixtures composed of oils, surfactants, and occasionally cosolvents. The ability of these formulations and methods to produce nanoemulsions or fine oil-in-water (o/w) emulsions after moderate stirring and dilution by water phase along the GI tract. SNEDDS has garnered attention during recent years as it improves oral bioavailability, reduces drug dose, and increases drug protection from unsuitable environment in the gastrointestinal tract. It can solve the problems related to the dissolution and bioavailability of the Biopharmaceutics Classifcation System Class II and IV drugs. This review shortly describes the ambiguity between nanoemulsions and microemulsions, mechanism of self-emulsifications, composition and function of various excipients of SNEDDS. This review discusses characterization of SNEDDS, advantage of SNEEDS over other emulsion, biopharmaceutical aspects, and limitation as well as future views. The SNEDDS is a potential formulation for drug delivery. Owing to its small particle size, large surface area, high encapsulation efficiency, and high drug loading, the SNEDDS can improve the rate and extent of oral absorption by maximizing drug solubility in the intestinal absorption site. Moreover, because of the lipid-based formulation of SNEDDS, it can stimulate and enhance lymphatic transport of drugs to avoid hepatic first-pass metabolism, and thus improve their bioavailability.
- Open Access
- 8 March 2021
- Published by MDPI AG in Proceedings
- Vol. 62 (1) , 14
Pharmaceutical Cocrystals—A Review
The design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offers a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. This short review summarizes this highly topical field, covering why the topic is of interest in pharmaceutical formulation, the definitions and practical scope of cocrystals, cocrystal preparation and characterization, a comparison of different (traditional and novel) methods for cocrystal formation and the implications for regulatory control and intellectual property protection. Traditionally, cocrystals can be prepared by solvent evaporation method, grinding, and slurry method, but every method has its limitations for certain conditions. The current trend for cocrystal formation uses sophisticated methods such as the hot melt extrusion method, spray-drying method, supercritical fluid technology and the newest method: laser irradiation. The purpose of the development of a new method is not only to overcome the limitation of traditional cocrystallization methods, but also to generate simpler steps and a continuous process for the production of the cocrystal product. This article provides a brief explanation of each method that can be used to generate pharmaceutical cocrystals as well as evaluation of cocrystals. This article also covers how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.
- 8 March 2021
- Published by MDPI AG in Proceedings
- Vol. 62 (1) , 14
Open AccessPharmaceutical Cocrystals—A Review
The design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offers a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. This short review summarizes this highly topical field, covering why the topic is of interest in pharmaceutical formulation, the definitions and practical scope of cocrystals, cocrystal preparation and characterization, a comparison of different (traditional and novel) methods for cocrystal formation and the implications for regulatory control and intellectual property protection. Traditionally, cocrystals can be prepared by solvent evaporation method, grinding, and slurry method, but every method has its limitations for certain conditions. The current trend for cocrystal formation uses sophisticated methods such as the hot melt extrusion method, spray-drying method, supercritical fluid technology and the newest method: laser irradiation. The purpose of the development of a new method is not only to overcome the limitation of traditional cocrystallization methods, but also to generate simpler steps and a continuous process for the production of the cocrystal product. This article provides a brief explanation of each method that can be used to generate pharmaceutical cocrystals as well as evaluation of cocrystals. This article also covers how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.